Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: Results from the WHO World Health Survey

World Psychiatry

Volumn 12, Issue 3, 2013, Pages 251-257

  Moreno, Carmen ^a   Nuevo, Roberto ^b   Chatterji, Somnath ^c   Verdes, Emese ^c   Arango, Celso ^a   Ayuso Mateos, José Luis ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

access to health care; medical conditions; multinational study; physical health; Psychotic symptoms

Indexed keywords

ACCIDENT; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL CONSUMPTION; ANGINA PECTORIS; ARTHRITIS; ARTICLE; ASTHMA; DIABETES MELLITUS; DRUG USE; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HEALTH STATUS; HEALTH SURVEY; HEARING IMPAIRMENT; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENTAL DISEASE; MOUTH DISEASE; PRIORITY JOURNAL; PSYCHOSIS; SMOKING; SOCIOECONOMICS; SYMPTOM; TOOTH DISEASE; TUBERCULOSIS; VISUAL IMPAIRMENT; WORLD HEALTH ORGANIZATION;

EID: 84885136559     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20070     Document Type: Article

References (60)

1. Brown S, Kim M, Mitchell C, et al. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 2010; 196: 116-21.
2. Saha S, Chant D, McGrath J,. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64: 1123-31.
3. Tiihonen J, Lonnqvist J, Wahlbeck K, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009; 374: 620-7.
4. Laursen TM, Munk-Olsen T, Vestergaard M,. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry 2012; 25: 83-8.
5. von Hausswolff-Juhlin Y, Bjartveit M, Lindstrom E, et al. Schizophrenia and physical health problems. Acta Psychiatr Scand 2009: 119 (Suppl. 438): 15-21.
6. De Hert M, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 2011; 10: 52-77.
7. Leucht S, Burkard T, Henderson J, et al. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 2007; 116: 317-33.
8. Fleischhacker WW, Cetkovich-Bakmas M, De Hert M, et al. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry 2008; 69: 514-9.
9. Arango C, Bobes J, Kirkpatrick B, et al. Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS study. Eur Neuropsychopharmacol 2011; 21: 867-75.
10. De Hert M, Dekker JM, Wood D, et al. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 2009; 24: 412-24.
11. Kilbourne AM, Morden NE, Austin K, et al. Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. Gen Hosp Psychiatry 2009; 31: 555-63.
12. Goff DC, Sullivan LM, McEvoy JP, et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res 2005; 80: 45-53.
13. Truyers C, Buntinx F, De Lepeleire J, et al. Incident somatic comorbidity after psychosis: results from a retrospective cohort study based on Flemish general practice data. BMC Fam Pract 2011; 12: 132.
14. Walkup J, Akincigil A, Hoover DR, et al. Use of Medicaid data to explore community characteristics associated with HIV prevalence among beneficiaries with schizophrenia. Public Health Rep 2011; 126 (Suppl. 3): 89-101.
15. Saiz-Ruiz J, Saiz-Gonzalez MD, Alegria AA, et al. Impact of the Spanish Consensus on Physical Health of Patients with Schizophrenia. Rev Psiquiatr Salud Ment 2010; 3: 119-27.
16. Chen YH, Lin HC,. Poor clinical outcomes among pneumonia patients with schizophrenia. Schizophr Bull 2011; 37: 1088-94.
17. Arango C, Bobes J, Aranda P, et al. A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study. Schizophr Res 2008; 104: 1-12.
18. Bobes J, Arango C, Garcia-Garcia M, et al. Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res 2010; 119: 101-9.
19. Brown S, Inskip H, Barraclough B,. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212-7.
20. Kirkpatrick B,. Schizophrenia as a systemic disease. Schizophr Bull 2009; 35: 381-2.
21. Perala J, Suvisaari J, Saarni SI, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007; 64: 19-28.
22. Nuevo R, Chatterji S, Verdes E, et al. The continuum of psychotic symptoms in the general population: a cross-national study. Schizophr Bull 2012; 38: 475-85.
23. Rossler W, Riecher-Rossler A, Angst J, et al. Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr Res 2007; 92: 1-14.
24. Addington J, Penn D, Woods SW, et al. Social functioning in individuals at clinical high risk for psychosis. Schizophr Res 2008; 99: 119-24.
25. Saha S, Scott J, Varghese D, et al. The association between physical health and delusional-like experiences: a general population study. PLoS One 2011; 6: e18566.
26. McCloughen A, Foster K, Huws-Thomas M, et al. Physical health and wellbeing of emerging and young adults with mental illness: an integrative review of international literature. Int J Ment Health Nurs 2012; 21: 274-88.
27. Ustun TB, Chatterji S, Mechbal A, et al. Quality assurance in surveys: standards, guidelines and procedures. In: Household sample surveys in developing and transition countries. New York: Department for Economic and Social Affairs, 2005: 199-230.
28. Kessler RC, Ustun TB,. The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004; 13: 93-121.
29. Cooper L, Peters L, Andrews G,. Validity of the Composite International Diagnostic Interview (CIDI) psychosis module in a psychiatric setting. J Psychiatr Res 1998; 32: 361-8.
30. Rose GA,. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962; 27: 645-58.
31. Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370: 851-8.
32. Nuevo R, Chatterji S, Fraguas D, et al. Increased risk of diabetes mellitus among persons with psychotic symptoms: results from the WHO World Health Survey. J Clin Psychiatry 2011; 72: 1592-9.
33. Cohen J,. Statistical power analysis for the behavioral sciences. Hillsdale: Lawrence Erlbaum, 1988.
34. Oud MJ, Meyboom-de Jong B,. Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Fam Pract 2009; 10: 32.
35. Filik R, Sipos A, Kehoe PG, et al. The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand 2006; 113: 298-305.
36. Chen YH, Lee HC, Lin HC,. Prevalence and risk of atopic disorders among schizophrenia patients: a nationwide population based study. Schizophr Res 2009; 108: 191-6.
37. Pedersen MS, Benros ME, Agerbo E, et al. Schizophrenia in patients with atopic disorders with particular emphasis on asthma: a Danish population-based study. Schizophr Res 2012; 138: 58-62.
38. Ohta Y, Nakane Y, Mine M, et al. The epidemiological study of physical morbidity in schizophrenics - 2. Association between schizophrenia and incidence of tuberculosis. Jpn J Psychiatry Neurol 1988; 42: 41-7.
39. Volkov VP,. Respiratory diseases as a cause of death in schizophrenia. Probl Tuberk Bolezn Legk 2009; 6: 24-7.
40. Colton CW, Manderscheid RW,. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006; 3: A42.
41. Janardhanan T, Cohen CI, Kim S, et al. Dental care and associated factors among older adults with schizophrenia. J Am Dent Assoc 2011; 142: 57-65.
42. Arnaiz A, Zumarraga M, Diez-Altuna I, et al. Oral health and the symptoms of schizophrenia. Psychiatry Res 2011; 188: 24-8.
43. Wisdom JP, Manuel JI, Drake RE,. Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment. Psychiatr Serv 2011; 62: 1007-12.
44. Viertio S, Laitinen A, Perala J, et al. Visual impairment in persons with psychotic disorder. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 902-8.
45. Prager S, Jeste DV,. Sensory impairment in late-life schizophrenia. Schizophr Bull 1993; 19: 755-72.
46. de la Fontaine L, Schwarz MJ, Riedel M, et al. Investigating disease susceptibility and the negative correlation of schizophrenia and rheumatoid arthritis focusing on MIF and CD14 gene polymorphisms. Psychiatry Res 2006; 144: 39-47.
47. Eaton WW, Byrne M, Ewald H, et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 2006; 163: 521-8.
48. Sundquist K, Li X, Hemminki K, et al. Subsequent risk of hospitalization for neuropsychiatric disorders in patients with rheumatic diseases: a nationwide study from Sweden. Arch Gen Psychiatry 2008; 65: 501-7.
49. Roberts L, Roalfe A, Wilson S, et al. Physical health care of patients with schizophrenia in primary care: a comparative study. Fam Pract 2007; 24: 34-40.
50. Kilbourne AM, McCarthy JF, Welsh D, et al. Recognition of co-occurring medical conditions among patients with serious mental illness. J Nerv Ment Dis 2006; 194: 598-602.
51. Munk-Jorgensen P, Mors O, Mortensen PB, et al. The schizophrenic patient in the somatic hospital. Acta Psychiatr Scand 2000; 102 (Suppl. 407): 96-9.
52. Fernandez-Egea E, Bernardo M, Heaphy CM, et al. Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophr Bull 2009; 35: 437-42.
53. Henderson DC, Ettinger ER,. Schizophrenia and diabetes. Int Rev Neurobiol 2002; 51: 481-501.
54. Ferentinos P, Dikeos D,. Genetic correlates of medical comorbidity associated with schizophrenia and treatment with antipsychotics. Curr Opin Psychiatry 2012; 25: 381-90.
55. De Hert M, Cohen D, Bobes J, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 2011; 10: 138-51.
56. Heald A, Montejo AL, Millar H, et al. Management of physical health in patients with schizophrenia: practical recommendations. Eur Psychiatry 2010; 25 (Suppl. 2): S41-5.
57. Tosh G, Clifton A, Bachner M,. General physical health advice for people with serious mental illness. Cochrane Database Syst Rev 2011: CD008567.
58. Bobes J, Alegria AA, Saiz-Gonzalez MD, et al. Change in psychiatrists' attitudes towards the physical health care of patients with schizophrenia coinciding with the dissemination of the consensus on physical health in patients with schizophrenia. Eur Psychiatry 2011; 26: 305-12.
59. Stanghellini G, Langer AI, Ambrosini A, et al. Quality of hallucinatory experiences: differences between a clinical and a non-clinical sample. World Psychiatry 2012; 11: 110-3.
60. Berkson J,. Limitations of the application of fourfold table analysis to hospital data. Biometrics 1946; 2: 47-53.